Literature DB >> 21979799

Increasing adherence for latent tuberculosis infection therapy with health department-administered therapy.

Andrea T Cruz1, Jeffrey R Starke.   

Abstract

Therapy is almost universally recommended for children with latent tuberculosis infection, but long courses of therapy can decrease adherence to drug therapy. The only variable positively associated with adherence to latent tuberculosis infection therapy in our population was health department-assisted administration of drugs (odds ratio, 7.2; 95% confidence interval, 3.8-13.8).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21979799     DOI: 10.1097/INF.0b013e318236984f

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

Review 1.  Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countries.

Authors:  Andrea T Cruz; Jeffrey R Starke; Mark N Lobato
Journal:  Curr Opin Pediatr       Date:  2014-02       Impact factor: 2.856

Review 2.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05

3.  Four months of rifampicin monotherapy for latent tuberculosis infection in children.

Authors:  Chi Eun Oh; Dick Menzies
Journal:  Clin Exp Pediatr       Date:  2021-10-29

4.  Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017.

Authors:  Andrea T Cruz; Jeffrey R Starke
Journal:  Emerg Infect Dis       Date:  2019-03       Impact factor: 6.883

5.  [Factors associated with treatment adherence for tuberculosis infection].

Authors:  Carmen R Gallardo; María Teresa Gea Velázquez de Castro; Juana Requena Puche; Juan José Miralles Bueno; María Vicenta Rigo Medrano; Jesús M Aranaz Andrés
Journal:  Aten Primaria       Date:  2013-12-09       Impact factor: 1.137

Review 6.  Interventions for improving adherence to treatment for latent tuberculosis infection: a systematic review.

Authors:  Anke L Stuurman; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anouk M Oordt-Speets; Andreas Sandgren; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-06-08       Impact factor: 3.090

7.  Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.

Authors:  Andreas Sandgren; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anke Stuurman; Anouk Oordt-Speets; Marieke J van der Werf
Journal:  BMC Infect Dis       Date:  2016-05-17       Impact factor: 3.090

8.  Lessons learned from two interventions designed to increase adherence to LTBI treatment in Latino youth.

Authors:  Melbourne F Hovell; Katharine E Schmitz; Elaine J Blumberg; Linda Hill; Carol Sipan; Lawrence Friedman
Journal:  Contemp Clin Trials Commun       Date:  2018-08-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.